July 18, 2023
It’s official! A global centre of excellence in health is to be created in Nice. Bringing together 600 doctors, researchers and industrialists, and bringing together 10 laboratories, this hospital-university organisation will coordinate Research and Development as well as clinical trials in the field of respiratory diseases linked to ageing. It will give new impetus to the health sector, the development of which is one of Nice’s priorities.
The Nice University Hospital Centre (CHU), the Côte d’Azur University, Inria and Inserm have been chosen and awarded €20 million by the French National Research Agency (ANR) for the creation of a University Hospital Institute (IHU) in Nice, as part of the France 2030 plan.
This health cluster will soon be coming to life in Nice, thanks to the investment of researchers, carers and academics from Nice University Hospital, the Côte d’Azur University, INRIA Sophia and INSERM, who have helped to build this project from a scientific point of view, as well as the 4 research teams involved: the Inria 3IA Côte-d’Azur centre, the Institut de Pharmacologie Cellulaire et Moléculaire (IPMC), the Institut de Recherche sur le Vieillissement et le Cancer (IRCAN) and the Institut de biologie du développement.
A new university hospital institute in Nice: RespirERA
Christian ESTROSI, Mayor of Nice, Chairman of the Supervisory Board of the Nice University Hospital and Deputy Chairman of the Nice Region, has worked closely with the Mayor of Nice and Chairman of the Supervisory Board of the Nice University Hospital. This major centre will bring together more than 600 people, including doctors, researchers and industrialists, and will bring together around ten laboratories of national and European stature.
It will focus on several respiratory diseases: lung cancer, chronic obstructive pulmonary disease (COPD), interstitial fibrosis of the lung, cystic fibrosis and respiratory allergies such as asthma.
It will be the first French and European organisation to bring together on the same site unique national and international expertise in fundamental, translational and clinical research, training, innovation and care in the field of respiratory diseases associated with ageing.
The RespirERA project will be led by Professor Paul Hofman, who is behind the discovery of an early detection test for lung cancer, and Professor Charles-Hugo Marquette, a lung specialist and oncologist at Nice University Hospital.
This national centre of excellence will be the birthplace of tomorrow’s medicine. Thanks to this pooling of resources and skills, everything should be faster and certainly better. And above all, we’ll be developing the medicine of tomorrow!Professor Paul Hofman